Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-26

Clinical Trial Update: Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis [Phase 3]

View source ↗

Summary

Phase 3 trial of DWC20155/DWC20156 combination therapy for gastritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DWC20155
  • DWC20156

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Gastritis | Phase 3 | Status: TERMINATED